Sinopharm applies for vaccine market approval
chinadaily.com.cn |
Updated: 2020-11-25 14:29
Share
Share - WeChat
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.
- New penalties planned for violations related to radioactive waste management
- Best practices in youth cultural exchange released at Chongqing conference
- Yearender: China's 2025 space endeavors have seen new milestones
- HR conference sparks discussion on talent potentials in AI era
- Exhibition of entries for 6th China animal specimen competition opens in Shanghai
- Steam train ice sculpture wows Harbin ice festival
